Pharma giant in India buys Concert Pharmaceuticals in $576M deal

An Indian drugmaker will buy Lexington’s Concert Pharmaceuticals (NASDAQ: CNCE) in a cash deal valued at an initial $576 million, the two companies …

Read more at www.bizjournals.com